FENNEC PHARMACEUTICALS INC. — Net Income by Fiscal Year
29 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2c6d6658-81e2-4355-9348-0190e56db655/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-9.7M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-036182 |
| FY 2024 | $-436.0k | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003710 |
| FY 2023 | $-16.0M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-004383 |
| FY 2022 | $-23.7M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004948 |
| FY 2021 | $-17.3M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002334 |
| FY 2020 | $-18.1M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-043756 |
| FY 2019 | $-12.8M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-021132 |
| FY 2018 | $-9.9M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014220 |
| FY 2017 | $-7.0M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-017571 |
| FY 2016 | $-2.8M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-017299 |
| FY 2015 | $-659.0k | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-090604 |
| FY 2014 | $-2.2M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-020272 |
| FY 2013 | $-110.5M | 1996-09-03 – 2014-03-31 | evidence 0001144204-14-031132 |
| FY 2012 | $-113.2M | 1996-09-03 – 2013-03-31 | evidence 0001144204-13-028056 |
| FY 2011 | $-101.3M | 1996-09-03 – 2012-03-31 | evidence 0001144204-12-028850 |
| FY 2010 | $-5.2M | 2010-01-01 – 2010-12-31 | evidence 0001144204-13-019057 |
| FY 2009 | $-3.0M | 2009-01-01 – 2009-12-31 | evidence 0001144204-11-046552 |
| FY 2008 | $-13.6M | 2008-01-01 – 2008-12-31 | evidence 0001144204-11-046552 |
| FY 2007 | $-13.4M | 2007-01-01 – 2007-12-31 | evidence 0001144204-11-046552 |
| FY 2006 | $-16.4M | 2006-01-01 – 2006-12-31 | evidence 0001144204-11-046552 |
| FY 2005 | $-13.9M | 2005-01-01 – 2005-12-31 | evidence 0001144204-11-046552 |
| FY 2004 | $-6.9M | 2003-07-01 – 2004-06-30 | evidence 0001144204-11-046552 |
| FY 2003 | $-17.8M | 2002-07-01 – 2003-06-30 | evidence 0001144204-11-046552 |
| FY 2002 | $-3.7M | 2001-07-01 – 2002-06-30 | evidence 0001144204-11-046552 |
| FY 2001 | $-2.5M | 2000-07-01 – 2001-06-30 | evidence 0001144204-11-046552 |
| FY 2000 | $-1.6M | 1999-07-01 – 2000-06-30 | evidence 0001144204-11-046552 |
| FY 1999 | $-958.0k | 1998-07-01 – 1999-06-30 | evidence 0001144204-11-046552 |
| FY 1998 | $-398.0k | 1997-07-01 – 1998-06-30 | evidence 0001144204-11-046552 |
| FY 1997 | $-37.0k | 1996-07-01 – 1997-06-30 | evidence 0001144204-11-046552 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
FENNEC PHARMACEUTICALS INC. — all facts · Revenue · Operating Income